Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA–salt hypertension-induced vascular dementia in rats
- 337 Downloads
Vascular dementia and hypertension are increasing day by day, with a high degree of co-occurrence. Tremendous amount of research work is required so that new pharmacological agents may be identified for their appropriate therapeutic utility to combat different dementing disorders.
This study investigates the effect of natrium diethyldithiocarbamate trihydrate (NDDCT), a nuclear factor kappa-B (NF-κB) inhibitor, as well as lisinopril, an angiotensin converting enzyme (ACE) inhibitor, on deoxycorticosterone acetate (DOCA) hypertension-induced vascular dementia in rats.
DOCA was used to induce hypertension and associated vascular dementia. Morris water maze (MWM) was used for testing learning and memory. Endothelial function was assessed by acetylcholine-induced endothelium-dependent relaxation of aortic strips. Different biochemical estimations were used to assess oxidative stress (aortic superoxide anion, serum and brain thiobarbituric acid reactive species, and brain glutathione), nitric oxide levels (serum nitrite/nitrate), and cholinergic activity (brain acetyl cholinesterase activity).
DOCA treatment significantly raised the mean arterial blood pressure of rats, and these hypertensive rats performed poorly on MWM, reflecting impairment of learning and memory. DOCA treatment also impaired vascular endothelial function and different biochemical parameters. Treatments of NDDCT as well as lisinopril significantly attenuated DOCA hypertension-induced impairment of learning and memory, endothelial dysfunction, and changes in various biochemical levels.
DOCA–salt hypertension induces vascular dementia in rats. NF-κB as well as ACE inhibitors may be considered as potential pharmacological agents for the management of hypertension-induced vascular dementia.
KeywordsNuclear factor kappa-B Angiotensin converting enzyme Endothelial dysfunction Morris water maze Alzheimer’s disease Oxidative stress
The authors are thankful to the Department of Pharmaceutical Sciences and Drug Research, Faculty of Medicine, Punjabi University, Patiala, Punjab, India for providing all the necessary facilities and funding to conduct this research. We are also thankful to Mr. A.S. Jaggi, Assistant Prof. in Pharmacology for his valuable suggestions.
- Anthony JD, Gary LP, Lisa AL, Douglas RS (2009) Role of NFκB in age-related vascular endothelial dysfunction in humans. Aging 1(8):678–680Google Scholar
- Beutler E, Duron O, Kelly B (1963) Reduced glutathione estimation. J Lb Clinical Med 61:82Google Scholar
- Bockman CS, Jeffries WB, Pettinger WA, Abel PW (1992) Reduced contractile sensitivity and vasopressin receptor affinity in DOCA–salt hypertension. Am J Physiol 262:1752–1758Google Scholar
- Borde P, Mohan M, Kasture S (2011) Effect of myricetin on deoxycorticosterone acetate DOCA–salt-hypertensive rats. Nat Prod Res 7:1–11Google Scholar
- Kandlikar SS, Fink GD (2011) Mild DOCA–salt hypertension sympathetic system and the role of renal nerves. Am J Physiol Heart Circ Physiol PMID: 21357502Google Scholar
- Kim TI, Lee YK, Park SG, Choi IS, Ban JO, Park HK et al (2009) L-Theanine an amino acid in green tea attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 47(11):1601–1610PubMedCrossRefGoogle Scholar
- Lorenza MM, Salvetti M, Belotti E, Paini A, Rosei CA, Aggiusti C, et al. (2011) Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function as assessed by flow mediated vasodilatation in hypertensive patients. Blood Press PMID: 21332412Google Scholar
- Monsuez JJ, Gesquière-Dando A, Rivera S (2011) Cardiovascular prevention of cognitive decline. Cardiol Res Pract PMID: 21318115Google Scholar
- Moretti A, Gorini A, Villa RF (2011) Pharmacotherapy and prevention of vascular dementia. CNS Neurol Disord Drug Targets PMID: 21294702Google Scholar
- Parle M, Singh N (2004) Animal models for testing memory. Asia Pacific J Pharmacol 16:101–120Google Scholar
- Sharma B, Singh N (2011) Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology PMID: 21225418Google Scholar
- Silva PS, Fontana V, Palei AC, Sertório JT, Biagi C, Tanus-Santos JE (2011) Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. Eur J Clin Pharmacol PMID: 21305271Google Scholar
- Szasz T, Linder AE, Davis RP, Burnett R, Fink GD, Watts SW (2010) Allopurinol does not decrease blood pressure or prevent the development of hypertension in the DOCA–salt rat model. J Cardiovasc Pharmacol PMID: 20881613Google Scholar
- Wehling M, Groth H (2011) Challenges of longevity in developed countries vascular prevention of dementia as an immediate clue to tackle an upcoming medical social and economic stretch. Neurodegener Dis PMID: 21228549Google Scholar
- Yang Q, Xue HM, Wong WT, Tian XY, Huang Y, Tsui SK et al (2011) AVE3085 an enhancer of endothelial nitric oxide synthase restores endothelial function and reduces blood pressure in spontaneously hypertensive rats. Br J Pharmacol. doi: 101111/j1476-5381201101308x